Shannon Miller, a seven-time Olympic medalist, was diagnosed with ovarian cancer at 33 after missing three warning signs ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall survival (OS) benefit in ovarian cancer, phase III study results showed.

More than two years after a positive topline readout, AstraZeneca has to face the reality that a lack of an overall survival ...

Ovarian cancer is frequently referred to as a “silent killer,” because it develops secretly and generally isn’t discovered until late. Some women don’t recognize what are in fact the daily ...

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no ...

KEYNOTE-B96 is the first trial to show overall survival (OS) improvement with an immune checkpoint inhibitor-based treatment ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

One study from Canada concluded in 2023 that hairdressing and accountancy, among other jobs, correlated with a higher risk of ovarian cancer.